stock
Xylo Technologies Ltd.
NASDAQ | XYLO
5.02
USD
0.00
(0.00%
)AT CLOSE (AS OF Aug 13, 2025)
$6.6M
MARKET CAP
-
P/E Ratio
-8
EPS
$5.9
52 Week High
$2.7
52 Week Low
LIFE SCIENCES
Sector
XYLO Chart
Recent Chart
Price Action
1D
Candles
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
XYLO Technicals
XYLO Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $6.7M |
| Total Revenue | $30M |
| Cost Of Revenue | $23M |
| Costof Goods And Services Sold | $23M |
| Operating Income | -$8M |
| Selling General And Administrative | $7.2M |
| Research And Development | $4.9M |
| Operating Expenses | $15M |
| Investment Income Net | - |
| Net Interest Income | -$1.1M |
| Interest Income | - |
| Interest Expense | $1.1M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3.7M |
| Income Before Tax | -$12M |
| Income Tax Expense | -$257K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$12M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$11M |
| Ebitda | -$7.5M |
| Net Income | -$6M |
Revenue & Profitability
Earnings Performance
XYLO Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $38M |
| Total Current Assets | $21M |
| Cash And Cash Equivalents At Carrying Value | $8.8M |
| Cash And Short Term Investments | $8.8M |
| Inventory | $0 |
| Current Net Receivables | $5.4M |
| Total Non Current Assets | $17M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $9.7M |
| Intangible Assets Excluding Goodwill | $9.7M |
| Goodwill | $5.1M |
| Investments | - |
| Long Term Investments | $1.6M |
| Short Term Investments | $5.9M |
| Other Current Assets | $885K |
| Other Non Current Assets | - |
| Total Liabilities | $20M |
| Total Current Liabilities | $18M |
| Current Accounts Payable | $6M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $6.4M |
| Total Non Current Liabilities | $1.5M |
| Capital Lease Obligations | $0 |
| Long Term Debt | $496K |
| Current Long Term Debt | $6.4M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $6.9M |
| Other Current Liabilities | $6.1M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $18M |
| Treasury Stock | - |
| Retained Earnings | -$108M |
| Common Stock | - |
| Common Stock Shares Outstanding | $721K |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$1.8M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $3.7M |
| Capital Expenditures | $12K |
| Change In Receivables | - |
| Change In Inventory | $161K |
| Profit Loss | - |
| Cashflow From Investment | $2.4M |
| Cashflow From Financing | -$998K |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $0 |
| Dividend Payout Common Stock | $0 |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$12M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $6.7M |
| Total Revenue | $30M |
| Cost Of Revenue | $23M |
| Costof Goods And Services Sold | $23M |
| Operating Income | -$8M |
| Selling General And Administrative | $7.2M |
| Research And Development | $4.9M |
| Operating Expenses | $15M |
| Investment Income Net | - |
| Net Interest Income | -$1.1M |
| Interest Income | - |
| Interest Expense | $1.1M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3.7M |
| Income Before Tax | -$12M |
| Income Tax Expense | -$257K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$12M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$11M |
| Ebitda | -$7.5M |
| Net Income | -$6M |
Dividends
| Field | Value |
|---|---|
| Ex Dividend Date | 2022-12-19 |
| Declaration Date | 2022-12-08 |
| Record Date | 2022-12-20 |
| Payment Date | 2022-12-28 |
| Amount | 0.85 |
XYLO Profile
Xylo Technologies Ltd. Profile
Sector: LIFE SCIENCES
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company is headquartered in Tel Aviv-Yafo, Israel.
Discover more tools and features to empower your trading
Explore FeaturesMarket data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.